Send the following on WhatsApp
Continue to Chat三特異性新藥抗病毒 1 期臨床亮眼!Novartis 攜 Molecular Partners 啟動第 2、3 期試驗 https://geneonline.news/novartis_molecular-partners_ensovibep/
三特異性新藥抗病毒 1 期臨床亮眼!Novartis 攜 Molecular Partners 啟動第 2、3 期試驗 https://geneonline.news/novartis_molecular-partners_ensovibep/